AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Webinar: Is Oversight a Burden or Pivotal to Operational Efficiency?

Tuesday, May 24, 2022  |  1:00pm – 2:00pm EDT


As the complexity of clinical trials continues to increase, the importance of CROs to the pharmaceutical industry has increased significantly. Outsourcing allows pharmaceutical companies to utilize on-demand services, improving operational efficiencies by accessing therapeutic expertise and geographic reach. This reflects a sharper focus on core competencies and a shift to allow CROs to manage and conduct clinical trials.

The use of KPIs for ongoing risk management from ICH E6 (R2) creates both opportunities and challenges in the sponsor-CRO collaboration. However, the forthcoming ICH E8 (R1) and ICH E6 (R3) guidelines focus on Quality by Design (QbD) to gain efficiencies in conducting clinical trials – significantly impacting oversight.


Key Learning Objectives:

  • Selection, implementation, and use of KPIs in a sponsor-CRO collaboration.
  • Challenges associated with metric definitions – what if the CRO’s system doesn’t capture the data? Or if their process is different?
  • Importance of context in interpreting KPIs.
  • The often, over-looked human aspect – the benefits of addressing mindset and culture change.
  • Tools provided by ICH E6 and E8 guidance’s to drive efficiencies in clinical trials.
  • How organizations can improve their operational efficiencies by adopting automation, standardization, and eliminating unnecessary duplicate processes/technology.



  • Stephen Crow
    Associate Director, Clinical Performance, Global Clinical Development Operations; Jazz Pharmaceuticals
  • Keith Dorricott
    MCC Ambassador, and Lead of the MCC Site Selection & Start-Up Process Metrics Development Work Group; Director, Dorricott Metrics & Process Improvement Ltd.; Metrics Subject Matter Expert, WCG Avoca
  • Elvin Thalund
    Director, Industry Strategy; Oracle Health Sciences



Hosted by Oracle Health Sciences